These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. HSPG2 overexpression independently predicts poor survival in patients with acute myeloid leukemia. Zhou X, Liang S, Zhan Q, Yang L, Chi J, Wang L. Cell Death Dis; 2020 Jun 30; 11(6):492. PubMed ID: 32606327 [Abstract] [Full Text] [Related]
32. Down-Regulation of miR-186 Correlates with Poor Survival in de novo Acute Myeloid Leukemia. Zhang TJ, Wang YX, Yang DQ, Yao DM, Yang L, Zhou JD, Deng ZQ, Wen XM, Guo H, Ma JC, Lin J, Qian J. Clin Lab; 2016 Jun 30; 62(1-2):113-20. PubMed ID: 27012040 [Abstract] [Full Text] [Related]
38. TET2 expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia. Zhang TJ, Zhou JD, Yang DQ, Wang YX, Wen XM, Guo H, Yang L, Lian XY, Lin J, Qian J. J Cell Physiol; 2018 Aug 30; 233(8):5838-5846. PubMed ID: 29219176 [Abstract] [Full Text] [Related]
39. Correlation of long non-coding RNA taurine-upregulated gene 1 with disease conditions and prognosis, as well as its effect on cell activities in acute myeloid leukemia. Qin J, Bao H, Li H. Cancer Biomark; 2018 Aug 30; 23(4):569-577. PubMed ID: 30452403 [Abstract] [Full Text] [Related]